Literature DB >> 18931837

Combined evaluation of preoperative FDG uptake on PET, ground-glass opacity area on CT, and serum CEA level: identification of both low and high risk of recurrence in patients with resected T1 lung adenocarcinoma.

Kotaro Higashi1, Tsutomu Sakuma, Kengo Ito, Seiji Niho, Yoshimichi Ueda, Takeshi Kobayashi, Ryuzo Sekiguchi, Tomoko Takahashi, Takashi Kato, Hisao Tonami.   

Abstract

PURPOSE: Patients with the same pathological stage of lung adenocarcinoma display marked variability in postoperative recurrence. The aim of this study was to predict the postoperative prognosis in patients with small-sized pulmonary adenocarcinoma on the basis of FDG uptake on PET, the extent of ground-glass opacity (GGO) on CT, and serum carcinoembryonic antigen (CEA) levels.
METHODS: We evaluated 87 patients (40 men, 47 women; mean age 64 years, age range 42-84 years) with lung adenocarcinoma of 3.0 cm or smaller. The level of FDG uptake (low or high), the extent of GGO (GGO or solid), and serum CEA levels (<20 ng/ml or > or =20 ng/ml) were correlated with the pathological findings of cell dedifferentiation, aggressiveness, N factor, and the incidence of relapse.
RESULTS: The patients were divided into the following four groups: those with the GGO pattern (group I, 13 patients), those with solid pattern and low FDG uptake (group II, 35 patients), those with solid pattern, high FDG uptake, and CEA <20 ng/ml (group III, 32 patients), and those with solid pattern, high FDG uptake, and CEA > or =20 ng/ml (group IV, 7 patients). The incidence of cell dedifferentiation, aggressiveness, and lymph node metastasis were significantly different among the groups (p<0.0001); . The 5-year disease-free survival rates were 100% in group I, 80.1% in group II, 43.7% in group III, and 16.7% in group IV (p<0.0001).
CONCLUSION: Combined evaluation of preoperative FDG uptake, GGO, and serum CEA level may enable patients with T1 lung adenocarcinoma at low risk and at high risk of postoperative recurrence to be identified.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18931837     DOI: 10.1007/s00259-008-0961-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  27 in total

1.  Modified scar grade: a prognostic indicator in small peripheral lung adenocarcinoma.

Authors:  Akiko M Maeshima; Toshiro Niki; Arafumi Maeshima; Tesshi Yamada; Haruhiko Kondo; Yoshihiro Matsuno
Journal:  Cancer       Date:  2002-12-15       Impact factor: 6.860

2.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

3.  Quantification of ground-glass opacity on high-resolution CT of small peripheral adenocarcinoma of the lung: pathologic and prognostic implications.

Authors:  E A Kim; T Johkoh; K S Lee; J Han; K Fujimoto; J Sadohara; P S Yang; T Kozuka; O Honda; S Kim
Journal:  AJR Am J Roentgenol       Date:  2001-12       Impact factor: 3.959

4.  18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study.

Authors:  Kotaro Higashi; Kengo Ito; Yoshinori Hiramatsu; Tsutomu Ishikawa; Tsutomu Sakuma; Ichiro Matsunari; Gencho Kuga; Katsuyuki Miura; Takahiro Higuchi; Hisao Tonami; Itaru Yamamoto
Journal:  J Nucl Med       Date:  2005-02       Impact factor: 10.057

5.  Prognosis and histologic features of small pulmonary adenocarcinoma based on serum carcinoembryonic antigen level and computed tomographic findings.

Authors:  Kazuya Takamochi; Junji Yoshida; Mitsuyo Nishimura; Tomoyuki Yokose; Satoshi Sasaki; Yutaka Nishiwaki; Kazuya Suzuki; Kanji Nagai
Journal:  Eur J Cardiothorac Surg       Date:  2004-05       Impact factor: 4.191

6.  Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients.

Authors:  Heiko Schöder; Yusuf E Erdi; Kenneth Chao; Mithat Gonen; Steven M Larson; Henry W D Yeung
Journal:  J Nucl Med       Date:  2004-04       Impact factor: 10.057

7.  Can FDG-PET be used to predict growth of stage I lung cancer?

Authors:  M Tann; K Sandrasegaran; H T Winer-Muram; S G Jennings; M E Welling; J W Fletcher
Journal:  Clin Radiol       Date:  2008-04-14       Impact factor: 2.350

8.  Lung cancer patients showing pure ground-glass opacity on computed tomography are good candidates for wedge resection.

Authors:  Haruhiko Nakamura; Hisashi Saji; Akihiko Ogata; Takamoto Saijo; Shinya Okada; Harubumi Kato
Journal:  Lung Cancer       Date:  2004-04       Impact factor: 5.705

9.  Prognostic value of FDG uptake in early stage non-small cell lung cancer.

Authors:  François-Xavier Hanin; Max Lonneux; Julien Cornet; Philippe Noirhomme; Corinne Coulon; Julien Distexhe; Alain J Poncelet
Journal:  Eur J Cardiothorac Surg       Date:  2008-05       Impact factor: 4.191

10.  Predictive factors for survival in surgically resected clinical IA peripheral adenocarcinoma of the lung.

Authors:  Yukinori Sakao; Takahiko Nakazono; Toru Sakuragi; Masafumi Natsuaki; Tsuyoshi Itoh
Journal:  Ann Thorac Surg       Date:  2004-04       Impact factor: 4.330

View more
  7 in total

Review 1.  Controversies on lung cancers manifesting as part-solid nodules.

Authors:  Rowena Yip; Kunwei Li; Li Liu; Dongming Xu; Kathleen Tam; David F Yankelevitz; Emanuela Taioli; Betsy Becker; Claudia I Henschke
Journal:  Eur Radiol       Date:  2017-08-23       Impact factor: 5.315

2.  Risk factors associated with recurrence of surgically resected node-positive non-small cell lung cancer.

Authors:  Yoichi Ohtaki; Kimihiro Shimizu; Kyoichi Kaira; Toshiteru Nagashima; Kai Obayashi; Seshiru Nakazawa; Seiichi Kakegawa; Hitoshi Igai; Mitsuhiro Kamiyoshihara; Masahiko Nishiyama; Izumi Takeyoshi
Journal:  Surg Today       Date:  2016-01-19       Impact factor: 2.549

3.  Prognostic value of the ratio of ground glass opacity on computed tomography in small lung adenocarcinoma: A meta-analysis.

Authors:  Xiao-Hui Miao; Yan-Wen Yao; Dong-Mei Yuan; Yan-Ling Lv; Ping Zhan; Tang-Feng Lv; Hong-Bing Liu; Yong Song
Journal:  J Thorac Dis       Date:  2012-06-01       Impact factor: 2.895

4.  Silver Nanoscale Hexagonal Column Chips for Detecting Cell-free DNA and Circulating Nucleosomes in Cancer Patients.

Authors:  Hiroaki Ito; Katsuyuki Hasegawa; Yuuki Hasegawa; Tadashi Nishimaki; Kazuyoshi Hosomichi; Satoshi Kimura; Motoi Ohba; Hiroshi Yao; Manabu Onimaru; Ituro Inoue; Haruhiro Inoue
Journal:  Sci Rep       Date:  2015-05-21       Impact factor: 4.379

5.  Identification of Factors for the Preoperative Prediction of Tumour Subtype and Prognosis in Patients with T1 Lung Adenocarcinoma.

Authors:  Wang-Yu Zhu; Yong-Kui Zhang; Zhen-da Chai; Xiao-Fei Hu; Lin-Lin Tan; Zhao-Yu Wang; Zhi-Jun Chen; Han-Bo Le
Journal:  Dis Markers       Date:  2016-12-26       Impact factor: 3.434

Review 6.  Incidental, subsolid pulmonary nodules at CT: etiology and management.

Authors:  Jessica L Seidelman; Jeffrey L Myers; Leslie E Quint
Journal:  Cancer Imaging       Date:  2013-09-23       Impact factor: 3.909

Review 7.  [Surgery for Pulmonary Multiple Ground Glass Opacities].

Authors:  Qun Wang; Wei Jiang; Junjie Xi
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-06-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.